Pharmafile Logo
Pharmafocus logo
Advanced Search
astrazeneca-sign

AstraZeneca’s Farxiga meets Phase 3 primary endpoint in heart failure

August 20, 2019
Manufacturing and Production, Sales and Marketing AstraZeneca, cardiovascular disease, farxiga

New Phase 3 data has been unveiled for AstraZeneca’s Farxiga (dapagliflozin), confirming that the SGLT2 inhibitor met its primary composite …

News

California man gets eight years in prison for falsely labelling erectile dysfunction drug

August 20, 2019
Manufacturing and Production FDA, erectile dysfunction, labellnig, pharma, tadalafil

A man from Walnut, California has been sentenced to eight years and four months in federal prison for illegally importing …

News
5204602349_c87b204860_z

FDA turns down Sarepta’s DMD drug over safety concerns

August 20, 2019
Manufacturing and Production DMD, FDA, approval safety, pharma, sarepta

The FDA has declined to approve Sarepta Therapeutics’ Duchenne muscular dystrophy (DMD) drug, citing safety concerns including risk of infection …

News
fda2outsideweb

FDA greenlights Nebriva’s Xenleta for community-acquired bacterial pneumonia

August 20, 2019
Manufacturing and Production, Sales and Marketing FDA, Nabriva, US, Xenleta, pharma, pneumonia

The FDA has awarded approval in the US to Nebriva Therapeutics’ Xenleta (lefamulin) for the treatment of adult patients with …

News
bacteria-3662695_960_720

Drop in prescriptions for antibiotic leads to fewer cases of superbug in Wales

August 20, 2019
Manufacturing and Production AMR, Antibiotics, C difficile, C. difficile, pharma, superbug

Cuts to the number of prescriptions for antibiotics have led to a drop in the number of cases of the …

News
733px-reduction_gear

Finding the needle in the haystack of rare disease

August 19, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Genomenon, Rare Genomics Institute, pharma, rare disease

Through the use of Genomenon’s AI-driven Mastermind Genomic Search Engine, the Rare Genomics Institute succeeded where a leading genetics laboratory …

Feature
celgene_1_02

Celgene’s Inrebic becomes second FDA-approved therapy for rare bone marrow disorder

August 19, 2019
Sales and Marketing Cancer, Cerlgene, FDA, Inrebic, pharma, rare disease

Celgene is celebrating the approval in the US of its Janus kinase (JAK) 2 inhibitor Inrebic (fedratinib) in the treatment …

News
brexit_predictions

British and American healthcare professionals predict further delays to Brexit as Europeans expect no-deal

August 19, 2019
Sales and Marketing EU, UK, US, brexit, brexit delay, healthcare, no-deal, pharma

The majority of healthcare professionals in Europe, Britain and America think Brexit will happen. However they do not believe that …

News
abbvie_0

AbbVie scoops up FDA approval for Rinvoq in moderately to severely active rheumatoid arthritis

August 19, 2019
Sales and Marketing AbbVie, FDA, Rinvoq, pharma, rheumatoid arthritis

The FDA has awarded marketing authorisation to AbbVie’s Rinvoq (upadacitinib) for the treatment of moderately to severely active rheumatoid arthritis, …

News
boris_johnson

UK Government calls on social media companies to fight misinformation surrounding vaccines

August 19, 2019
Sales and Marketing MMR, anti-vaxxers, measles, pharma, vaccination, vaccines

Boris Johnson has called on social media companies to come together to discuss ways in which they can promote accurate …

News
novartis_outside_1

Novartis exec sold off shares before Zolgensma data scandal was revealed

August 19, 2019
Sales and Marketing AveXis, Novartis, Shares, Zolgensma, pharma, stock market

An unnamed Novartis executive sold 925,400 Swiss francs (£778,665) worth of shares in the firm just weeks before the FDA …

News

Roche’s cancer drug Rozlytrek scores double approval from FDA

August 16, 2019
Medical Communications Cancer, Roche, Rozlytrek, lung cancer, oncology

The FDA has approved Roche’s Rozlytrek (entrectinib) as a treatment for adults with ROS1-positive, metastatic non-small cell lung cancer (NSCLC). …

News
cannabis-2152604_960_720

Hundreds of patients turn to private cannabis clinics in UK

August 16, 2019
Medical Communications Marijuana, NHS, UK, cannabis, medicinal cannabis, pharma

Hundreds of people have turned to private clinics, in an effort to gain access to medicinal cannabis in the UK, …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

August 16, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Air pollution, CAR-T therapy, HIV, Kymriah, Medicare, Novartis, Yescarta, Zolgensma

Novartis’ faulty data scandal dominated the headlines this week, as the Swiss firm faced fierce backlash over covering up the …

News

Pfizer recall two batches of migraine drug Relpax

August 16, 2019
Medical Communications FDA, Pfizer, Relpax, migraine, pharma, recall

Pfizer has recalled two lots of its migraine drug Relpax over concerns about microbiological contamination. In a statement on the …

News
ipos0_l

Regeneron invest $800 million into New York facilities

August 15, 2019
Medical Communications East Greenbush, New York, Regeneron, pharma

Regeneron is investing $800 million into its New York production facilities. The firm is planning to build a four story …

News
regeneron

Regeneron therapy halves LDL cholesterol levels in rare genetic condition

August 15, 2019
Research and Development Regeneron, evinacumab, pharma, rare disease

Regeneron has reported a strong showing for its investigational angiopoietin-like 3 (ANGPTL3) antibody evinacumab in the treatment of the rare …

News
lilly_building_with_american_flag_web

Lilly’s Taltz beats Janssen’s Tremfya at Phase 4 in plaque psoriasis

August 15, 2019
Research and Development Eli Lilly, Taltz, Tremfya, pharma, psoriasis

Eli Lilly has unveiled new Phase 4 data supporting the efficacy and safety of Taltz (ixekizumab) when compared to Janssen’s …

News
28246711066_52e38bc591_z

Britain call on companies to bid for 24 hour Brexit medicines shipping service contract

August 15, 2019
Business Services, Sales and Marketing UK, brexit, britain, medicines, pharma

The British Government is calling on logistics companies to bid for a £25 million contract to run express freight containers …

News

FDA approve new drug for treatment-resistant TB

August 15, 2019
Research and Development FDA, TB, US, pharma, pretomanid, tuberculosis

The US FDA has approved BPaL, the TB Alliance’s treatment for drug-resistant tuberculosis (TB). The US regulator gave the go-ahead …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026